These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24831229)

  • 1. Fecal lactoferrin and intestinal permeability are effective non-invasive markers in the diagnostic work-up of chronic diarrhea.
    Caccaro R; D'Incà R; Martinato M; Pont ED; Pathak S; Frigo AC; Sturniolo GC
    Biometals; 2014 Oct; 27(5):1069-76. PubMed ID: 24831229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of lactoferrin in feces for differential diagnosis in diarrhea].
    Fried K; Tárkányi K; Prinz G; Bán E
    Orv Hetil; 2002 Sep; 143(37):2141-4. PubMed ID: 12434630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal calprotectin and lactoferrin as noninvasive markers of pediatric inflammatory bowel disease.
    Joishy M; Davies I; Ahmed M; Wassel J; Davies K; Sayers A; Jenkins H
    J Pediatr Gastroenterol Nutr; 2009 Jan; 48(1):48-54. PubMed ID: 19172123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential value of faecal lactoferrin as a screening test in hospitalized patients with diarrhoea.
    van Langenberg DR; Gearry RB; Wong HL; Ward M; Gibson PR
    Intern Med J; 2010 Dec; 40(12):819-27. PubMed ID: 19849752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O; Naumann M; Shastri Y; Povse N; Stein J
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between fecal lactoferrin and inflammatory bowel disease.
    Dai J; Liu WZ; Zhao YP; Hu YB; Ge ZZ
    Scand J Gastroenterol; 2007 Dec; 42(12):1440-4. PubMed ID: 17852860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal lactoferrin is a sensitive and specific marker of disease activity in children and young adults with inflammatory bowel disease.
    Walker TR; Land ML; Kartashov A; Saslowsky TM; Lyerly DM; Boone JH; Rufo PA
    J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):414-22. PubMed ID: 17414136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fecal lactoferrin in identifying and management of inflammatory bowel disease].
    Pac-Kozuchowska E; Krawiec P; Mroczkowska-Juchkiewicz A
    Pol Merkur Lekarski; 2014 Jul; 37(217):61-4. PubMed ID: 25154203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of hepatocyte growth factor as a local acute phase response marker in the bowel: the clinical impact of a rapid diagnostic test for immediate identification of acute bowel inflammation.
    Sorour AE; Lönn J; Nakka SS; Nayeri T; Nayeri F
    Cytokine; 2015 Jan; 71(1):8-15. PubMed ID: 25174881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea.
    Di Leo V; D'Incà R; Diaz-Granado N; Fries W; Venturi C; D'Odorico A; Martines D; Sturniolo GC
    Am J Gastroenterol; 2003 Oct; 98(10):2245-52. PubMed ID: 14572575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?
    Sidhu R; Wilson P; Wright A; Yau CW; D'Cruz FA; Foye L; Morley S; Lobo AJ; McAlindon ME; Sanders DS
    Aliment Pharmacol Ther; 2010 Jun; 31(12):1365-70. PubMed ID: 20331581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease.
    Caccaro R; D'Incá R; Sturniolo GC
    Expert Rev Clin Immunol; 2010 Jul; 6(4):551-8. PubMed ID: 20594128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal lactoferrin in discriminating inflammatory bowel disease from irritable bowel syndrome: a diagnostic meta-analysis.
    Zhou XL; Xu W; Tang XX; Luo LS; Tu JF; Zhang CJ; Xu X; Wu QD; Pan WS
    BMC Gastroenterol; 2014 Jul; 14():121. PubMed ID: 25002150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of fecal biomarkers in inflammatory bowel disease.
    Sutherland AD; Gearry RB; Frizelle FA
    Dis Colon Rectum; 2008 Aug; 51(8):1283-91. PubMed ID: 18543035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort.
    Burri E; Manz M; Rothen C; Rossi L; Beglinger C; Lehmann FS
    Clin Chim Acta; 2013 Feb; 416():41-7. PubMed ID: 23178549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal markers: calprotectin and lactoferrin.
    Abraham BP; Kane S
    Gastroenterol Clin North Am; 2012 Jun; 41(2):483-95. PubMed ID: 22500530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC; Huang JL; Chang CJ; Kong MS
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.